Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Nelson

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapyM D Prados, C Scott, W J Curran, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06B W Corn, C Dolinskas, C Scott, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology GroupD F Nelson, M Diener-West, J Horton, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1995
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02K J Murray, D F Nelson, C Scott, et al.
Journal of Neuro-Oncology|January 1, 1985
Survival and prognosis of patients with astrocytoma with atypical or anaplastic featuresD F Nelson, J S Nelson, D R Davis, et al.
Cancer|February 19, 2000
Stereotactic radiosurgery for recurrent ependymomaS L Stafford, B E Pollock, R L Foote, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1983
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG studyD F Nelson, D Schoenfeld, A S Weinstein, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?D F Nelson, B W Gillespie, M D Diener, et al.
Cancer|January 1, 1977
The role of radiation therapy in localized resectable intestinal non-Hodgkin's lymphoma in childrenD F Nelson, J R Cassady, D Traggis, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Clinical trials of WR-2721 with radiation therapyA L Blumberg, D F Nelson, M Gramkowski, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapyM D Prados, C Scott, W J Curran, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06B W Corn, C Dolinskas, C Scott, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology GroupD F Nelson, M Diener-West, J Horton, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1995
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02K J Murray, D F Nelson, C Scott, et al.
Journal of Neuro-Oncology|January 1, 1985
Survival and prognosis of patients with astrocytoma with atypical or anaplastic featuresD F Nelson, J S Nelson, D R Davis, et al.
Cancer|February 19, 2000
Stereotactic radiosurgery for recurrent ependymomaS L Stafford, B E Pollock, R L Foote, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1983
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG studyD F Nelson, D Schoenfeld, A S Weinstein, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?D F Nelson, B W Gillespie, M D Diener, et al.
Cancer|January 1, 1977
The role of radiation therapy in localized resectable intestinal non-Hodgkin's lymphoma in childrenD F Nelson, J R Cassady, D Traggis, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Clinical trials of WR-2721 with radiation therapyA L Blumberg, D F Nelson, M Gramkowski, et al.
Pageof 5